New Study Finds RIVA ‘Leading the Pack’ in Automated IV Compounding Systems

November 28, 2012

RIVA, the fully automated IV compounding system manufactured by Intelligent Hospital Systems (IH Systems), is ahead of competitors in overall performance, meeting business case expectations and customer satisfaction, according to a new study of IV automation systems by independent healthcare research firm KLAS.

The study, “U.S. IV Automation: Robots and Workflow Solutions in 2012,” examined five pharmacy automation systems, including RIVA and its leading competitors. The report found that RIVA’s initial data scores were highest among all the systems studied. RIVA technology also received high marks for having needed functionality, being ready for widespread industry use and customers that would buy it again. Significantly, RIVA was the only IV automation system in the study to have all customers report it was meeting or exceeding anticipated ROI.

“Safety reduces costs, and RIVA provides hospitals with a very high ‘safety dividend’ that is a unique and invaluable aspect of its ROI,” said Dr. Niels Erik Hansen, president and CEO of Intelligent Hospital Systems. “RIVA’s technology has been engineered to prevent human error, which is the most common source of medication contamination and can have tragic results as evidenced by the recent meningitis outbreak.”

Click here for the story.

Share This Story

Back

“Safety reduces costs, and RIVA provides hospitals with a very high ‘safety dividend’ that is a unique and invaluable aspect of its ROI. RIVA’s technology has been engineered to prevent human error, which is the most common source of medication contamination and can have tragic results as evidenced by the recent meningitis outbreak.” -Dr. Niels Erik Hansen, President and CEO, IH Systems